| Measure Type | High Priority Measure? | Collection Type(s) |
|---|---|---|
| Process | yes | MIPS CQM |
Measure Description
Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the tissue specimen was received by the pathologist